USPTO trademark

VEVADEQ

Under examinationUSPTOWord markClass 5

"VEVADEQ" is a word mark owned by Pfizer Inc., filed at the USPTO on April 20, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Pfizer Inc. portfolioGet this data via the API
Official USPTO record
VEVADEQ trademark as filed
As filed with the USPTO
Status
Under examination
Since October 5, 2026
Filed
April 20, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99774827
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns VEVADEQ

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Pfizer Inc.

PFE · New York, United States

6,826 trademarks in the portfolioView company

Representative

Yana Gorbach

Pfizer Inc.

Goods and services

What the mark covers

The products and services VEVADEQ is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Antifungal preparations; Smoking cessation preparations; Vaccines for human use

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of letter of suspension e-mailed
  2. Letter of suspension e-mailed
  3. Suspension letter written
  4. Teas/email correspondence entered
  5. Correspondence received in law office
  6. Teas response to suspension inquiry received
  7. Teas withdrawal of attorney received-firm retains
  8. Teas change of correspondence received
  9. Attorney/dom.rep.revoked and/or appointed
  10. Teas revoke/app/change addr of atty/dom rep received

7 earlier steps on the official record.

FAQ

About VEVADEQ

Who owns the trademark "VEVADEQ"?

The USPTO trademark "VEVADEQ" (application 99774827) is owned by Pfizer Inc.

What is the status of "VEVADEQ"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VEVADEQ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019db7f0-2b54-7025-ae6c-c9c5b743fb69
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019db7f0-2b54-7025-ae6c-c9c5b743fb69",
  "object": "trademark",
  "mark_text": "VEVADEQ",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99774827",
  "filing_date": "2026-04-20",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Pfizer Inc.",
      "entity_id": "ent_019f2853-15ff-713b-878b-ed770179b310"
    }
  ]
}